UV Flu Technologies introduces the UV 400 VIRAGUARD air purification product

NewsGuard 100/100 Score

UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") wishes to advise it has recently acquired the assets of AmAirpure, Inc. in order to implement management's plans to move forward as an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality("IAQ") industry sector.

The Company is very pleased today to announce the launch of its flagship product, the UV 400 VIRAGUARD, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to actually trap and destroy harmful microbes. Extensive independent testing by EPA and FDA certified laboratories confirms the proprietary system captures and kills many airborne bacteria and viruses including Influenza A and H1N1 at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.

Recent statistics show that the U.S. IAQ market generated over $7.7 billion in 2008 with the equipment segment accounting for $3.6 billion. Early year end results for 2009 show continued strength across the entire sector. Continuing attention given to the health effects of toxic mold, the outbreak of infectious diseases such as swine flu, and the increase in chronic respiratory diseases such as asthma have resulted in significant interest and growth in this rapidly growing market.

As a result of the coveted FDA listing as a medical device, UV Flu Technologies is confidently ramping up production towards servicing sales into the early adopter target market sector which includes high risk environments such as hospitals, medical practitioner's offices and institutions. Future sales efforts are anticipated to broaden the scope to include a wide variety of public facilities and consumer interests.

As of December 16, 2009, UV Flu Technologies, Inc. entered into an Asset Purchase Agreement with AmAirpure, Inc., whereby the Company acquires certain of their assets relating to the design, development, manufacture, sale and distribution of technology and products including air purification systems. The agreement includes the transfer of certain shares and contains customary representations and warranties and indemnification provisions.

SOURCE: UV Flu Technologies, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Avian flu's leap to humans: Understanding risks and prevention strategies